Outcome of patients with low-risk and intermediate-1-risk myelodysplastic syndrome after hypomethylating agent failure: A report on behalf of the MDS Clinical Research Consortium

Author: Jabbour Elias J.   Garcia-Manero Guillermo   Strati Paolo   Mishra Asmita   Al Ali Najla H.   Padron Eric   Lancet Jeffrey   Kadia Tapan   Daver Naval   O'Brien Susan   Steensma David P.   Sekeres Mikkael A.   Gore Steven D.   Dezern Amy   Roboz Gail J.   List Alan F.   Kantarjian Hagop M.   Komrokji Rami S.  

Publisher: Blackwell Publishing

E-ISSN: 1097-0142|121|6|876-882

ISSN: 0008-543X

Source: Cancer, Vol.121, Iss.6, 2015-03, pp. : 876-882

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract